Over the past twenty days of trading, Immune Therapeutics (OTCMKTS: IMUN), from June 04, 2020 to July 02, 2020 there is a potential Short Squeeze about to happen because of an increase in short volume over the past twenty days with very little cover volume. Because of this the Squeeze Report trend indicator issued a […]
The post Immune Therapeutics (OTCMKTS:IMUN) Short Squeeze appeared first on Squeeze Report News.
Market Wire News is a media platform, the information on this page was provided by Squeeze Report News via Quote Media. Read our full disclaimer.
News, Short Squeeze, Breakout and More Instantly...
Orlando, Florida, July 07, 2020 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC Pink: IMUN) (“Immune” “IMUN” or the “Company”), a biopharmaceutical company focused on the development of therapies for the treatment of Infectious diseases con...
Winter Park, Florida--(Newsfile Corp. - June 9, 2020) - Immune Therapeutics, Inc. (OTC Pink: IMUN), announced today that equity partner, Cytocom, Inc., has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to study CYTO-201 for the treatment...
Winter Park, Florida--(Newsfile Corp. - May 6, 2020) - Immune Therapeutics, Inc. (OTC Pink: IMUN) ("Immune" "IMUN" or the "Company") is a late-stage biopharmaceutical company focused on the development of T-cell activation immunotherapy to treat life-threatening or chronic diseases announced i...
